Skip to content

Leap Therapeutics started by Ladenburg at buy, target $18

March 7, 2017

Leap Therapeutics (LPTX) was Initiated by Ladenburg Thalmann to “Buy” and the brokerage firm has set the Price Target at $18. Ladenburg Thalmann advised their Clients and Investors in a research report released on Mar 7, 2017.

http://bit.ly/2mgJRqO

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: